Clinical Trials Browser

Phase 2/3 × Stomach Neoplasms × Paclitaxel × Clear all

NCT06221748 2024-04-03

DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy

Phase 2/3 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT05427383 2023-12-19

KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy

Phase 2/3 Recruiting

Gastrointestinal

Stomach Neoplasms